Latest Drug Approvals news
FDA Approves Zevaskyn for Rare, Genetic Skin Disorder
posted April 29th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Delays Final Approval of Novavax COVID Vaccine
posted April 4th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Qfitlia to Cut Bleeding Episodes in Patients With Hemophilia
posted April 2nd
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Cabozantinib for Previously Treated Advanced Neuroendocrine Tumors
posted March 31st
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Cancer Risk ID"d for Asian American, NHPI Population 
Paternal Exposure to Valproate Not Linked to Offspring Neurodevelopmental Disorders 
Chemo-Free Combo of Four Targeted Therapies Shows Promise in Metastatic Breast Cancer 
Drug Retention in Spondyloarthritis Varies With Socioeconomic Status Related Articles
Countries Involved in U.S. Clinical Trials Do Not Gain Timely Access to Approved Medicines 
FDA Picks George Tidmarsh to Head Center for Drug Evaluation and Research 
Approved-Label Populations for New Drugs Broader Than Trial Populations Monthly Specialist Briefings
Stay Connected
